Applied dna announces pricing of $4.2 million registered direct offering

Stony brook, n.y.--(business wire)---- $apdn--applied dna sciences, inc. (nasdaq: apdn) (the “company”), a leader in polymerase chain reaction (pcr)-based dna manufacturing, announced today that it has entered into a securities purchase agreement with an institutional investor, providing for the purchase and sale of 1,496,400 shares of common stock (or common stock equivalents) at a price of $2.80 per share, in a registered direct offering, resulting in total gross proceeds of approximately $4.2 million,
APDN Ratings Summary
APDN Quant Ranking